Follow
Jimmy Van den Eynden
Jimmy Van den Eynden
Associate professor at Ghent University
Verified email at ugent.be - Homepage
Title
Cited by
Cited by
Year
Evaluation of anatomy based reconstruction for partial volume correction in brain FDG-PET
K Baete, J Nuyts, K Van Laere, W Van Paesschen, S Ceyssens, ...
Neuroimage 23 (1), 305-317, 2004
1402004
Glycine and glycine receptor signalling in non-neuronal cells
J Van den Eynden, S SahebAli, N Horwood, S Carmans, B Brône, ...
Frontiers in Molecular Neuroscience 2, 799, 2009
982009
Recurrent promoter mutations in melanoma are defined by an extended context-specific mutational signature
NJ Fredriksson, K Elliott, S Filges, J Van den Eynden, A Ståhlberg, ...
PLoS genetics 13 (5), e1006773, 2017
752017
Elevated pyrimidine dimer formation at distinct genomic bases underlies promoter mutation hotspots in UV-exposed cancers
K Elliott, M Boström, S Filges, M Lindberg, J Van den Eynden, A Ståhlberg, ...
PLoS genetics 14 (12), e1007849, 2018
722018
Dopamine transporter SPECT using fast kinetic ligands: 123I-FP-β-CIT versus 99mTc-TRODAT-1
K Van Laere, L De Ceuninck, R Dom, J Van den Eynden, H Vanbilloen, ...
European journal of nuclear medicine and molecular imaging 31, 1119-1127, 2004
682004
Lack of detectable neoantigen depletion signals in the untreated cancer genome
J Van den Eynden, A Jiménez-Sánchez, ML Miller, E Larsson
Nature genetics 51 (12), 1741-1748, 2019
632019
Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinib
J Guan, S Fransson, JT Siaw, D Treis, J Van den Eynden, D Chand, ...
Molecular Case Studies 4 (4), a002550, 2018
582018
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events
A Ashouri, VI Sayin, J Van den Eynden, SX Singh, T Papagiannakopoulos, ...
Nature communications 7 (1), 13197, 2016
572016
Dorsal Unpaired Median Neurons of Locusta migratoria Express Ivermectin- and Fipronil-Sensitive Glutamate-Gated Chloride Channels
D Janssen, C Derst, R Buckinx, J Van den Eynden, JM Rigo, ...
Journal of neurophysiology 97 (4), 2642-2650, 2007
552007
The inhibitory neurotransmitter glycine modulates macrophage activity by activation of neutral amino acid transporters
S Carmans, JJA Hendriks, K Thewissen, J Van den Eynden, P Stinissen, ...
Journal of neuroscience research 88 (11), 2420-2430, 2010
492010
Targeting filamin A reduces macrophage activity and atherosclerosis
S Bandaru, C Ala, R Salimi, MK Akula, M Ekstrand, S Devarakonda, ...
Circulation 140 (1), 67-79, 2019
482019
SomInaClust: detection of cancer genes based on somatic mutation patterns of inactivation and clustering
J Van den Eynden, AC Fierro, LPC Verbeke, K Marchal
BMC bioinformatics 16, 1-12, 2015
482015
ALK ligand ALKAL2 potentiates MYCN‐driven neuroblastoma in the absence of ALK mutation
M Borenäs, G Umapathy, WY Lai, DE Lind, B Witek, J Guan, ...
The EMBO journal 40 (3), e105784, 2021
442021
Phosphoproteome and gene expression profiling of ALK inhibition in neuroblastoma cell lines reveals conserved oncogenic pathways
J Van den Eynden, G Umapathy, A Ashouri, D Cervantes-Madrid, ...
Science signaling 11 (557), eaar5680, 2018
422018
Mutational signatures are critical for proper estimation of purifying selection pressures in cancer somatic mutation data when using the dN/dS metric
J Van den Eynden, E Larsson
Frontiers in Genetics 8, 259796, 2017
402017
Simultaneous discovery of cancer subtypes and subtype features by molecular data integration
T Le Van, M Van Leeuwen, A Carolina Fierro, D De Maeyer, ...
Bioinformatics 32 (17), i445-i454, 2016
382016
Pathway relevance ranking for tumor samples through network-based data integration
LPC Verbeke, J Van den Eynden, AC Fierro, P Demeester, J Fostier, ...
PloS one 10 (7), e0133503, 2015
372015
11q deletion or ALK activity curbs DLG2 expression to maintain an undifferentiated state in neuroblastoma
JT Siaw, N Javanmardi, J Van den Eynden, DE Lind, S Fransson, ...
Cell reports 32 (12), 2020
342020
Somatic mutation patterns in hemizygous genomic regions unveil purifying selection during tumor evolution
J Van den Eynden, S Basu, E Larsson
PLoS genetics 12 (12), e1006506, 2016
332016
ATR inhibition enables complete tumour regression in ALK-driven NB mouse models
J Szydzik, DE Lind, B Arefin, Y Kurhe, G Umapathy, JT Siaw, A Claeys, ...
Nature communications 12 (1), 6813, 2021
292021
The system can't perform the operation now. Try again later.
Articles 1–20